Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Dalbavancin in Osteoarticular Infections Associated With Hip and Knee Replacements

NCT05046860 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nice as lead sponsor.

NCT NCT05046860
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05046860 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Dalbavancin in Osteoarticular Infections Associated With Hip and Knee Replacements
Lead sponsor
Centre Hospitalier Universitaire de Nice
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 7, 2022
Completion date
August 30, 2026
Enrollment
43 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarticular infection